The Quantellect read.As of Nov 19, 2026, 12 active firms cover Molina Healthcare Inc: 1 rate it Buy or better, 10 sit at Neutral, and 1 rate it Sell or worse, a neutral consensus. Targets span $124.00 to $230.00, a moderate spread. The average target of $192.42 sits 7% below the current $206.67. The rating mix has stayed broadly stable, with Buy-side ratings easing from 2 to 1 over recent months. On the fundamentals, the Street sees consensus EPS building from about $3.08 next quarter toward $9.54 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS12 active firms
Neutral
Strong Buy00%
Buy18%
Neutral1083%
Sell18%
Strong Sell00%
Based on 12 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$192.42
-6.9% downside
Average target across 12 active firms as of Nov 19, 2026 vs $206.67 current
Highest Target$230.00
Average Target$192.42
Lowest Target$124.00
Detailed analyst forecasts for MOH
Showing 1–12 of 12 named analysts shown · 12 active firms in the rating projection
As of Nov 19, 2026, 1 of 12 active firms rate MOH a Buy (10 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
MOH EPS & revenue forecast
EPS · NEXT QUARTER
$3.08
Range $2.28 – $3.81 · 13 analysts · +31% YoY
Next period, 13 analysts expect Molina Healthcare Inc to earn $3.08 a share (range $2.28 – $3.81), versus $2.35 a year earlier. Full-year consensus is $5.27, growing to $9.54 the year after.
REVENUE · NEXT QUARTER
$11.8B
Range $10.9B – $12.1B · 13 analysts · +9% YoY
Revenue is expected to reach $11.8B (range $10.9B – $12.1B), +8.9% year-over-year. Full-year consensus is $44.7B, rising to $47.6B next year.
Top analysts covering Molina Healthcare Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on MOH.
#1
Stephen Baxter
Wells Fargo · Rank #63
Neutral
$220.00+6.4% to target
Overall win rate
47%
+ Follow
#2
Erin Wright
Morgan Stanley · Rank #81
Neutral
$192.00-7.1% to target
Overall win rate
55%
+ Follow
#3
DM
David Macdonald
Truist Securities · Rank #111
Neutral
$225.00+8.9% to target
Overall win rate
50%
+ Follow
#4
Ben Hendrix
RBC Capital · Rank #150
Neutral
$222.00+7.4% to target
Overall win rate
44%
+ Follow
#5
Sarah James
Cantor Fitzgerald · Rank #159
Neutral
$209.00+1.1% to target
Overall win rate
37%
+ Follow
MOH stock forecast FAQ
What is MOH's average 12-month price target?+
The 12 active firms with a live target average $192.42 for Molina Healthcare Inc over the next 12 months, ranging from a $230.00 high to a $124.00 low, as of Nov 19, 2026.
Is MOH stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 12 active firms as of Nov 19, 2026, 1 rate it Buy or Strong Buy, 10 rate it Neutral, and 1 rate it Sell or Strong Sell.
What are the highest and lowest price targets for MOH?+
The Street-high target is $230.00 (TD Cowen), and the Street-low is $124.00 (Goldman Sachs). The average of all 12 active-firm targets is $192.42.
How many active Wall Street firms cover MOH?+
12 active firms have a recognized rating on Molina Healthcare Inc as of Nov 19, 2026, and 12 active firms carry a live 12-month price target.
Who is the most accurate analyst covering MOH?+
Among analysts who currently cover MOH, Stephen Baxter of Wells Fargo has the strongest overall Quantellect track record (Rank #63). Their current call is Neutral with a $220.00 target.
What is Molina Healthcare Inc's projected EPS for next quarter?+
The consensus estimate is $3.08 per share (range $2.28 – $3.81) across 13 analysts. Full-year EPS is projected at $5.27, rising to $9.54 the following year.
How much revenue is Molina Healthcare Inc expected to report next quarter?+
Consensus revenue is $11.8B (range $10.9B – $12.1B). Full-year revenue is projected at $44.7B, growing to $47.6B next year.
Have analysts been upgrading or downgrading MOH lately?+
As of Nov 19, 2026, 1 of 12 active firms rate MOH a Buy (10 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their MOH calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.